Medicare Enrolled
Dr. Cristina Porch-Curren, M.D.
Optician · Camarillo, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Porch-Curren from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Porch-Curren?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Porch-Curren
Dr. Cristina Porch-Curren is an optician specialist in Camarillo, CA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Porch-Curren performed 41,765 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Porch-Curren received a total of $17,141 from 43 pharmaceutical and/or device companies across 792 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Porch-Curren is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 3% volume in CA
$17,141 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗41,765
Medicare services
Top 3% in CA for optician
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Omalizumab injection (Xolair) for asthma/allergy | 19,950 | $30 | $50 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
4,858 | $3 | $10 |
| Allergy immunotherapy preparation A professional service involving the preparation and administration of one or more antigens. |
4,230 | $13 | $22 |
| Allergy skin patch test A diagnostic test where small amounts of potential allergens are applied to the skin to identify substances that cause an allergic reaction. |
2,789 | $5 | $31 |
| Skin allergy test A test where small amounts of potential allergens are injected into the skin to check for allergic reactions. |
2,398 | $7 | $14 |
| Allergy injection therapy, multiple injections A professional service involving the administration of multiple allergen injections. |
2,000 | $10 | $44 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,009 | $12 | $50 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
989 | $2 | $22 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
764 | $74 | $110 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
743 | $104 | $176 |
| Allergen injection administration Professional service for the administration of a single allergen injection. |
579 | $8 | $24 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
540 | $23 | $132 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
166 | $135 | $253 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
150 | $49 | $88 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
82 | $15 | $83 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
82 | $34 | $39 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
81 | $72 | $81 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
64 | $15 | $60 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
54 | $32 | $292 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
53 | $0 | $6 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
40 | $8 | $83 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
27 | $34 | $39 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
26 | $87 | $176 |
| Levalbuterol inhalation solution, 0.5 mg A 0.5 mg unit dose of FDA-approved levalbuterol inhalation solution administered via durable medical equipment. |
24 | $0 | $6 |
| Inhaled albuterol and ipratropium bromide via DME Administration of FDA-approved albuterol and ipratropium bromide medication through durable medical equipment. |
20 | $0 | $6 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
18 | $281 | $325 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
17 | $21 | $55 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
12 | $131 | $160 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$17,141
Total received (2018-2024)
Avg $2,449/year across 7 years
Top 10% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
792
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,652
2023
$3,164
2022
$2,567
2021
$1,881
2020
$1,887
2019
$1,859
2018
$2,131
Payments by company (2024)
GlaxoSmithKline, LLC.
$674
AstraZeneca Pharmaceuticals LP
$621
Amgen Inc.
$308
Regeneron Healthcare Solutions, Inc.
$287
Blueprint Medicines Corporation
$247
GENZYME CORPORATION
$209
PFIZER INC.
$187
Novartis Pharmaceuticals Corporation
$186
Optinose US, Inc.
$184
Incyte Corporation
$146
Takeda Pharmaceuticals U.S.A., Inc.
$132
Boehringer Ingelheim Pharmaceuticals, Inc.
$97
kaleo, Inc.
$75
BioCryst US Sales Co., LLC
$51
Hikma Pharmaceuticals USA
$48
Genentech USA, Inc.
$48
Pharming Healthcare, Inc.
$42
Octapharma USA, Inc.
$29
Kedrion Biopharma, Inc.
$24
Grifols USA, LLC
$19
LEO Pharma Inc.
$19
Merck Sharp & Dohme LLC
$16
Top 3 companies account for 43.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,136
AstraZeneca Pharmaceuticals LP
$2,684
Regeneron Healthcare Solutions, Inc.
$1,403
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,205
Amgen Inc.
$1,071
Takeda Pharmaceuticals U.S.A., Inc.
$861
PFIZER INC.
$731
GENZYME CORPORATION
$695
CSL Behring
$400
Genentech USA, Inc.
$378
Novartis Pharmaceuticals Corporation
$373
kaleo, Inc.
$372
Shire North American Group Inc
$353
Incyte Corporation
$333
Blueprint Medicines Corporation
$307
BioCryst US Sales Co., LLC
$283
Pharming Healthcare, Inc.
$275
Optinose US, Inc.
$237
Grifols USA, LLC
$225
Octapharma USA, Inc.
$218
OptiNose US, Inc.
$157
NOVARTIS PHARMACEUTICALS CORPORATION
$156
Teva Pharmaceuticals USA, Inc.
$152
Gilead Sciences, Inc.
$125
Kaleo, Inc.
$119
ABBVIE INC.
$118
SANOFI-AVENTIS U.S. LLC
$110
Merck Sharp & Dohme LLC
$86
Bio Products Laboratory USA, Inc.
$71
Merck Sharp & Dohme Corporation
$60
BioCryst Pharmaceuticals, Inc.
$50
Hikma Pharmaceuticals USA
$48
AIMMUNE THERAPEUTICS, INC.
$46
LEO Pharma Inc.
$44
Horizon Pharma plc
$40
Sunovion Pharmaceuticals Inc.
$40
ALK-Abello, Inc
$40
Xeris Pharmaceuticals, Inc.
$26
Aimmune Therapeutics, Inc.
$24
Kedrion Biopharma, Inc.
$24
Covis Pharma GmBH
$23
Horizon Therapeutics plc
$21
Mylan Specialty L.P.
$20
Top 3 companies account for 42.1% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · Albuked · Auvi-Q · BELSOMRA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CAPVAXIVE · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DUPIXENT · Descovy · Dymista · ELAPRASE · ENSTILAR · EOHILIA · EUCRISA · EVENITY · FASENRA · FIRAZYR · GARDASIL 9 · Gammaplex · HYQVIA · Haegarda · Hizentra · KEVEYIS · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Orladeyo · Otezla · PALFORZIA · PANZYGA · PNEUMOVAX 23 · PRE-PEN · PREVNAR 20 · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · QVAR · RINVOQ · RUCONEST · Ryaltris · SEEBRI · SHINGRIX · SPIRIVA · SPIRIVA RESPIMAT · STANDARDIZED · STIOLTO RESPIMAT · STRIVERDI RESPIMAT · SYMBICORT · TAKHZYRO · TAVNEOS · TEZSPIRE · TIMOTHY · TRELEGY ELLIPTA · UTIBRON · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
162
County median income
$107,327
Nearest hospital to ZIP centroid (approximate)
ST JOHNS REGIONAL MEDICAL CENTER
5.7 mi
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Porch-Curren is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Porch-Curren experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Porch-Curren performed 19,950 omalizumab injection (xolair) for asthma/allergy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Porch-Curren receive payments from pharmaceutical companies?
Yes. Dr. Porch-Curren received a total of $17,141 from 43 companies across 792 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Porch-Curren's costs compare to other opticians in Camarillo?
Dr. Porch-Curren's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Porch-Curren) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Camarillo
Browse opticians in Camarillo ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology